Indian pharma firms recall medications from US market Press Trust of India Jul 5, 2020 Lupin and Marksans Pharma recall diabetes drugs while Alembic and Aurbindo recall medicines that treat mental disorders
Aurobindo Pharma plans to launch 50-60 products in US in FY21 Press Trust of India Jun 22, 2020 Aurobindo Pharma's US business posted a growth of 27 per cent year-on-year to Rs 11,484 crore in FY20.
